Annual FCF
-$47.49 M
-$55.77 M-673.67%
December 31, 2023
Summary
- As of February 8, 2025, ATNM annual free cash flow is -$47.49 million, with the most recent change of -$55.77 million (-673.67%) on December 31, 2023.
- During the last 3 years, ATNM annual FCF has fallen by -$25.62 million (-117.14%).
- ATNM annual FCF is now -673.67% below its all-time high of $8.28 million, reached on December 31, 2022.
Performance
ATNM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$11.97 M
-$4.00 M-50.21%
September 30, 2024
Summary
- As of February 8, 2025, ATNM quarterly free cash flow is -$11.97 million, with the most recent change of -$4.00 million (-50.21%) on September 30, 2024.
- Over the past year, ATNM quarterly FCF has dropped by -$4.49 million (-59.88%).
- ATNM quarterly FCF is now -143.31% below its all-time high of $27.65 million, reached on June 30, 2022.
Performance
ATNM Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$34.82 M
-$820.00 K-2.41%
September 30, 2024
Summary
- As of February 8, 2025, ATNM TTM free cash flow is -$34.82 million, with the most recent change of -$820.00 thousand (-2.41%) on September 30, 2024.
- Over the past year, ATNM TTM FCF has increased by +$12.67 million (+26.67%).
- ATNM TTM FCF is now -412.25% below its all-time high of $11.15 million, reached on June 30, 2022.
Performance
ATNM TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ATNM Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -673.7% | -59.9% | +26.7% |
| 3 y3 years | -117.1% | -111.7% | -55.1% |
| 5 y5 years | -129.8% | -113.9% | -61.8% |
ATNM Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -673.7% | at low | -143.3% | +21.0% | -412.3% | +27.1% |
| 5 y | 5-year | -673.7% | at low | -143.3% | +21.0% | -412.3% | +27.1% |
| alltime | all time | -673.7% | at low | -143.3% | +21.0% | -412.3% | +27.1% |
Actinium Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$11.97 M(+50.2%) | -$34.82 M(+2.4%) |
| Jun 2024 | - | -$7.97 M(+7.9%) | -$34.00 M(-14.4%) |
| Mar 2024 | - | -$7.38 M(-1.4%) | -$39.72 M(-16.4%) |
| Dec 2023 | -$47.49 M(-673.7%) | -$7.49 M(-32.9%) | -$47.49 M(-0.6%) |
| Sep 2023 | - | -$11.15 M(-18.5%) | -$47.79 M(+12.7%) |
| Jun 2023 | - | -$13.69 M(-9.7%) | -$42.42 M(+3802.9%) |
| Mar 2023 | - | -$15.15 M(+94.4%) | -$1.09 M(-113.1%) |
| Dec 2022 | $8.28 M(-139.4%) | -$7.79 M(+34.7%) | $8.28 M(-24.9%) |
| Sep 2022 | - | -$5.79 M(-120.9%) | $11.02 M(-1.2%) |
| Jun 2022 | - | $27.65 M(-577.7%) | $11.15 M(-152.8%) |
| Mar 2022 | - | -$5.79 M(+14.6%) | -$21.14 M(+0.7%) |
| Dec 2021 | -$21.00 M(-4.0%) | -$5.05 M(-10.7%) | -$21.00 M(-6.5%) |
| Sep 2021 | - | -$5.66 M(+21.8%) | -$22.45 M(+3.0%) |
| Jun 2021 | - | -$4.64 M(-17.7%) | -$21.80 M(+0.6%) |
| Mar 2021 | - | -$5.65 M(-13.2%) | -$21.66 M(-1.0%) |
| Dec 2020 | -$21.87 M(+1.6%) | -$6.50 M(+30.0%) | -$21.87 M(+7.3%) |
| Sep 2020 | - | -$5.00 M(+10.9%) | -$20.38 M(-2.8%) |
| Jun 2020 | - | -$4.51 M(-22.9%) | -$20.98 M(-3.9%) |
| Mar 2020 | - | -$5.85 M(+16.7%) | -$21.84 M(+1.5%) |
| Dec 2019 | -$21.53 M(+4.2%) | -$5.02 M(-10.4%) | -$21.53 M(+3.5%) |
| Sep 2019 | - | -$5.60 M(+4.2%) | -$20.81 M(-4.9%) |
| Jun 2019 | - | -$5.37 M(-3.0%) | -$21.88 M(+5.5%) |
| Mar 2019 | - | -$5.54 M(+28.9%) | -$20.74 M(+0.4%) |
| Dec 2018 | -$20.67 M(-4.2%) | -$4.30 M(-35.6%) | -$20.67 M(+5.8%) |
| Sep 2018 | - | -$6.67 M(+57.7%) | -$19.54 M(+4.2%) |
| Jun 2018 | - | -$4.23 M(-22.6%) | -$18.74 M(-13.5%) |
| Mar 2018 | - | -$5.47 M(+72.4%) | -$21.66 M(+0.4%) |
| Dec 2017 | -$21.58 M(+3.5%) | -$3.17 M(-46.1%) | -$21.58 M(-4.8%) |
| Sep 2017 | - | -$5.88 M(-17.8%) | -$22.67 M(+1.4%) |
| Jun 2017 | - | -$7.15 M(+32.8%) | -$22.36 M(+4.3%) |
| Mar 2017 | - | -$5.38 M(+26.4%) | -$21.45 M(+2.9%) |
| Dec 2016 | -$20.85 M(+12.1%) | -$4.26 M(-23.6%) | -$20.85 M(+1.3%) |
| Sep 2016 | - | -$5.57 M(-10.7%) | -$20.58 M(+11.0%) |
| Jun 2016 | - | -$6.24 M(+30.3%) | -$18.53 M(+5.5%) |
| Mar 2016 | - | -$4.78 M(+20.0%) | -$17.56 M(-5.5%) |
| Dec 2015 | -$18.59 M | -$3.99 M(+13.0%) | -$18.59 M(-5.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | -$3.53 M(-33.1%) | -$19.65 M(-3.6%) |
| Jun 2015 | - | -$5.27 M(-9.4%) | -$20.39 M(+14.4%) |
| Mar 2015 | - | -$5.81 M(+15.1%) | -$17.82 M(+22.9%) |
| Dec 2014 | -$14.50 M(+129.8%) | -$5.05 M(+18.5%) | -$14.50 M(+34.2%) |
| Sep 2014 | - | -$4.26 M(+58.0%) | -$10.81 M(+32.2%) |
| Jun 2014 | - | -$2.70 M(+8.2%) | -$8.17 M(+25.9%) |
| Mar 2014 | - | -$2.49 M(+84.2%) | -$6.49 M(+2.8%) |
| Dec 2013 | -$6.31 M(+21.0%) | -$1.35 M(-16.8%) | -$6.31 M(-1.0%) |
| Sep 2013 | - | -$1.63 M(+60.2%) | -$6.37 M(-4.6%) |
| Jun 2013 | - | -$1.02 M(-56.1%) | -$6.68 M(+1.5%) |
| Mar 2013 | - | -$2.31 M(+63.2%) | -$6.58 M(+26.2%) |
| Dec 2012 | -$5.22 M(+907.6%) | -$1.42 M(-26.7%) | -$5.22 M(+20.7%) |
| Sep 2012 | - | -$1.93 M(+111.5%) | -$4.32 M(+81.1%) |
| Jun 2012 | - | -$914.30 K(-3.7%) | -$2.39 M(+63.1%) |
| Mar 2012 | - | -$949.10 K(+81.6%) | -$1.46 M(+182.6%) |
| Dec 2011 | -$517.60 K(-6735.9%) | -$522.50 K(<-9900.0%) | -$517.50 K(>+9900.0%) |
| Sep 2011 | - | $0.00(-100.0%) | -$100.00(-99.2%) |
| Jun 2011 | - | $9100.00(-322.0%) | -$13.30 K(-246.2%) |
| Mar 2011 | - | -$4100.00(-19.6%) | $9100.00(+16.7%) |
| Dec 2010 | $7800.00(-141.5%) | -$5100.00(-61.4%) | $7800.00(-20.4%) |
| Sep 2010 | - | -$13.20 K(-141.9%) | $9800.00(-44.9%) |
| Jun 2010 | - | $31.50 K(-683.3%) | $17.80 K(-228.1%) |
| Mar 2010 | - | -$5400.00(+74.2%) | -$13.90 K(-25.7%) |
| Dec 2009 | -$18.80 K(+34.3%) | -$3100.00(-40.4%) | -$18.70 K(+0.5%) |
| Sep 2009 | - | -$5200.00(+2500.0%) | -$18.60 K(+1.6%) |
| Jun 2009 | - | -$200.00(-98.0%) | -$18.30 K(-13.3%) |
| Mar 2009 | - | -$10.20 K(+240.0%) | -$21.10 K(+50.7%) |
| Dec 2008 | -$14.00 K(-28.6%) | -$3000.00(-38.8%) | -$14.00 K(-28.6%) |
| Sep 2008 | - | -$4900.00(+63.3%) | -$19.60 K(+1.0%) |
| Jun 2008 | - | -$3000.00(-3.2%) | -$19.40 K(+1.0%) |
| Mar 2008 | - | -$3100.00(-64.0%) | -$19.20 K(-2.0%) |
| Dec 2007 | -$19.60 K(+40.0%) | -$8600.00(+83.0%) | -$19.60 K(+78.2%) |
| Sep 2007 | - | -$4700.00(+67.9%) | -$11.00 K(+74.6%) |
| Jun 2007 | - | -$2800.00(-20.0%) | -$6300.00(+80.0%) |
| Mar 2007 | - | -$3500.00 | -$3500.00 |
| Dec 2006 | -$14.00 K | - | - |
FAQ
- What is Actinium Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals annual FCF year-on-year change?
- What is Actinium Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals quarterly FCF year-on-year change?
- What is Actinium Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals TTM FCF year-on-year change?
What is Actinium Pharmaceuticals annual free cash flow?
The current annual FCF of ATNM is -$47.49 M
What is the all time high annual FCF for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high annual free cash flow is $8.28 M
What is Actinium Pharmaceuticals annual FCF year-on-year change?
Over the past year, ATNM annual free cash flow has changed by -$55.77 M (-673.67%)
What is Actinium Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of ATNM is -$11.97 M
What is the all time high quarterly FCF for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high quarterly free cash flow is $27.65 M
What is Actinium Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, ATNM quarterly free cash flow has changed by -$4.49 M (-59.88%)
What is Actinium Pharmaceuticals TTM free cash flow?
The current TTM FCF of ATNM is -$34.82 M
What is the all time high TTM FCF for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high TTM free cash flow is $11.15 M
What is Actinium Pharmaceuticals TTM FCF year-on-year change?
Over the past year, ATNM TTM free cash flow has changed by +$12.67 M (+26.67%)